Skin disorders are commonly encountered in intensive care unit and pose numerous diagnostic and therapeutic dilemmas to the attending intensivist. Variable presentation of a single critical illness or a common presentation of multiple critical illnesses is few of the challenging aspects of such dermatologic disorders. Lack of in-depth understanding of the dermatological manifestations of systemic diseases in critically ill patients is one of the prime factors for difficulty in accurate diagnosis and management. Services of a dermatologist are immensely helpful and essential in diagnostic and therapeutic management of such disorders. The present article reviews in detail the clinical profile, diagnostic measures and therapeutic interventions of various dermatologic disorders encountered in the critically ill patients.
INTRODUCTION
Intensivists are faced with numerous challenges during the management of critically ill patients. Though, there are numerous diseases which becomes difficult to diagnose in patients during their stay in intensive care unit (ICU), the dilemmas presented by the cutaneous and dermatological disorders is sometimes difficult to overcome. Lack of deep understanding of the dermatological manifestations of systemic diseases in critically ill patients is one of the prime factors for difficulty in accurate diagnosis. It would be extremely difficult to treat dermatological disorders as these require the specialist services of a dermatologist. The skin plays a key role in maintaining homeostasis, thermoregulation containment of body fluids and protection of internal organs from environmental insults. The skin is readily available for clinical and physical examination, so inspection often provides important clues to the underlying disease. [1] However, the same cannot be held true for critically sick patients due to interplay of multiple factors and the above mentioned challenges. As such, there is a strong need felt among intensivists for reviewing these clinical diagnostic entities for better management of patients in ICU that develop dermatological manifestations. The aim of the present article is to review these difficult diagnostic scenarios and their subsequent management and the present article will focus on following broad areas relevant to critically ill patients:
• Drug reactions • Life threatening dermatoses • Common skin disorders in ICU • Purpuras.
DRUG REACTIONS
An adverse drug reaction may be defined as an undesirable clinical manifestation resulting from administration of a particular drug; this includes reaction due to overdose, predictable side-effects and unanticipated adverse manifestations. [2] Adverse drug reactions may be also be considered as an inevitable price the physicians have to pay for the benefits of modern drug therapy. [3] Patients receiving multiple drug therapy, such as the critically ill, are more prone to develop a drug eruption [ Table 1 ]. Patients with severe debilitating diseases, multi-organ dysfunction, and depressed immunity such as in acquired immune deficiency syndrome (AIDS) may appear to be at a greater risk of developing adverse drug reactions. [4] Generally, speaking these adverse drug reactions can be classified as follow: [5] 
Pattern of Drug Eruptions
The practice of unavoidable polypharmacy in ICU invariably increases the potential possibilities of severe drug eruptions and associated lesions. Many a times, these lesions can be easily confused with manifestations of some systemic illness. These eruptive patterns have to be recognized for appropriate medication and management [ Table 2 ].
Erythema Multiforme
Clinically, erythema multiforme (EM), involves macular, papular or urticarial lesions as well as classical iris or target lesions described preferentially on the distal extremities. [14] EM can possibly be caused by viral infections (Herpes Simplex, Mycoplasma, AIDS, Adenovirus, Cytomegalo Virus, Mumps, Polio, Variola, Varicella), Bacterial infections, Fungal infections, Drugs, Carcinomas/lymphomas, Pregnancy, Sarcoidosis, or Lupus erythematosus.
Steven Johnson Syndrome
Steven Johnson syndrome (SJS) comprises of extensive EM of trunk and mucous membranes accompanied by fever, malaise, myalgia and arthralgia. [15] Toxic Epidermal Necrolysis (TEN) (also known as Lyell Syndrome) first described in 1956 is characterized by extensive sheet like skin erosions with widespread purpuric macules or flat atypical target lesions accompanied by severe involvement of conjunctival, corneal, irideal, buccal, labial, and genital mucous membranes. [16, 17] Numerous drugs have been incriminated in causation of EM which has been enumerated in Table 3 .
Clinical Presentation
Lesions are dull red, flat or slightly raised maculo papules. [18] Typically target lesions are seen which have 3 zones: Central area of dusky erythema or purpura, middle paler zone of oedema and an outer ring of erythema with a well-defined edge. Lesions appear in successive crops and fade in 1-2 weeks. Classically, back of the hands, palms, wrist, feet, extensor aspect of the elbows, and knees are affected.
Management
The clinical utility of systemic steroids is still debated. [18] For severe cases, prednisolone at an initial dosage of 30-60 mg/day decreasing over a period of 1-4 weeks is usually given. Long term prophylactic use of acyclovir is quite effective in recurrent EM due to herpes simplex. Thalidomide has been used in a few cases to prevent relapses of recurrent EM. [19] Other drugs which have been [6] Erythroderma/ exfoliative dermatitis [7] Urticaria/ anaphylaxis [8] Pigmentation [9] Acute generalized exanthematous pustulosis [ 
TEN
There is a fair degree of overlap between SJS and TEN. [18] SJS may evolve into TEN and several drugs mentioned earlier can produce both entities. SJS, with occasional skin blisters and erosions covering less than 10% of the body surface area (BSA) is differentiated from TEN in which typically sheet like erosions involve more than 30% of the BSA.
[18]
Clinical Features of SJS and TEN
Clinically these pathologies are characterized by:
• Severe acute blistering disease associated with significant morbidity and mortality • There is often a recent history of drug ingestion.
Prodrome of fever, nausea, vomiting, diarrhea, malaise, headache, cough, sore throat, myalgia and arthralgia 1-14 days before the skin eruption. [1] • SJS: It is characterized by wide-spread red/purpuric macules or target lesions with sub-epidermal detachment of less than 10% of BSA at worse, mucosal erosions frequent [ Table 4 ].
• TEN: It presents as a variant of same process with epidermal detachment greater than 30% of the BSA [ Table 4 ].
Prognosis
There is appreciable mortality as a result of TEN, increasing from 5% in SJS to 10-15% in transitional SJS-TEN and 30-40% in TEN. Acute respiratory distress syndrome and multiple organ failure are the usual causes of death. [21] They are often precipitated by sepsis with septicemia mainly resulting from Staphylococcs aureus and Pseudomonas aeroginosa. [22] Other causes of higher mortality are pulmonary embolism and gastrointestinal bleeding. Prognosis can be predicted to a large extent with the help of Scorten prognosis score [ Table 5 ].
One point awarded for each parameter, Severity of illness score for toxic epidermal necrolysis (SCORTEN) derived by totaling scores.
Management should include but is not limited to [23] 
Life Threatening Dermatoses in Dermatology
Dermatology is usually thought of as an out-patient speciality with low mortality. However, some skin conditions can be very severe and the condition itself, 
Pemphigus Vulgaris
Pemphigus vulgaris is a rare life threatening autoimmune disease characterized by intraepithelial vesicles and bullae. Stratified squamous epithelium of both skin and mucosal surface is involved. The pathogenic process involves circulating Immunoglobulin G (IgG) antibodies directed against the intercellular substance of the epidermis. [1] It is a disease of middle age that affects children rarely, but patients are younger at presentation in India than in the western countries. [24] 
Clinical Features
It presents as oral lesions in 50-70% of patients which precede cutaneous lesions by a month. [25] Cutaneous lesions with predilection for scalp, face, axilla, groins, and pressure points develop. Flaccid blisters filled with clear fluid are often seen in this clinical entity. Nikolsky sign is positive in pemphigus vulgaris.
Treatment
Disease activity generally decreases with time and most relapses occur in the first 2 years of diagnosis. [26] 
Topical Therapy
Potent topical or intra-lesional steroids may reduce the requirement of oral steroids. Potassium permanganate wash and topical antiseptics may reduce the risk of cutaneous infection.
Systemic Therapy
Prednisolone 1-1.5 mg/kg/day is helpful in controlling the disease. [27] Combination of azathioprine and prednisolone is more useful. [27] Monthly intravenous pulses of cyclophosphamide with dexamethasone combined with low dose oral cyclophosphamide have been used with great success. [28] Tetracycline, cyclosporine, mycophenolate mofetil, plasmapheresis, IgG have been helpful in some cases.
Erythroderma
Erythroderma is the term applied to any inflammatory skin disease that affects more than 90% of the body surface. Generally it is caused by: [18] 
Clinical Features
Most patients complain of pruritus. The entire skin is red, scaly, indurated. Excoriations, peripheral edema, moderate symmetric lymph node enlargement are common. Mucous membranes usually are spared. There may be symptoms of orthostatic hypotension owing to increased insensible water loss. Congestive heart failure due to marked circulatory shunting through the skin may develop in patients with pre-existing cardiac disease. Thermoregulatory dysfunction can result in relative hypothermia and chills.
Treatment
Urea, electrolyte levels and fluid balance should be monitored. All non-essential drugs should be withdrawn. Soothing emollient cream or mild topical steroid is the first line of treatment. [29] Then treat the specific causes.
Acute GPP
Eruption may be ushered in by a sensation of burning.
The skin becomes dry/tender andis followed by high fever, malaise. Pre-existing psoriatic lesions become fiery and develop pinpoint pustules. Sheets of erythema and pustulation spread to involve previously unaffected skin, flexures and genitals.
[30]
Complications
• Death can occur in the acute stage • Hypoalbuminemia and hypocalcaemia may lead to Renal Tubular necrosis [31] • Deep Venous Thrombosis (DVT) in leg may cause pulm embolism • Staphylococcal infection may occur • Inflammatory polyarthritis is common.
Management
Management includes withdrawal of provocative factors, General measures to control symptoms, bed rest, bland local application, fluid, and protein replacement. Topical therapy can be used in the form of bland creams, but lotions are best. Weak corticosteroid creams may also be helpful. Systemic therapy can be administered in the form of retinoids which are considered as the treatment of choice. Response to high dose of acitretin (1 mg/kg/day) may be rapid and lower doses (0.5-0.75 mg/kg/day) may be sufficient to maintain control. [32] Psoralen and Ultra-Violet A therapy is effective in acute and sub-acute GPP. [33] Methotrexate is also effective. Oral or parenteral corticosteroid should be used only when urgent control of metabolic complications is needed. The short term effects of prednisolone are excellent. [34] 
Necrotizing Fasciitis
Necrotizing fasciitis may follow entry of Group A Streptococci, S. aureus, Aeromonas, Vibrio vulnificus including at least one anaerobic organism into skin most commonly on head and neck/limbs. [35] Patients present with hot, tender area of swelling, which is erythematous occasionally dusky. Bullae and necrosis of underlying tissue may intervene. [36] Treatment includes surgical debridement and intravenous antibiotics.
COMMON CUTANEOUS MANIFESTATIONS IN ICU

Candidiasis
Candidiasis is an infection caused by the yeast Candida albicans. Superficial infections of the mucous membranes and skin are most important and more common in ICU setting. Serious involvement of internal organs may result in septicemia, endocarditis and meningitis.
Clinical Features
Oral candidiasis
The commonest pattern is oral thrush characterized by sharply defined patch of creamy, curd like pseudo-membrane, which when removed leaves an erythematous area. Buccal mucosa, gums, and palate are commonly affected but in immunocompromised patients tongue may also be involved.
Flexural candidiasis
Most cases of cutaneous candidiasis occur in the skin folds or where occlusion from clothing or dressings produces abnormally moist conditions. Satellite lesions are classical. In patients of AIDS, hematologic malignancies, indwelling intravenous catheter or malnutrition, systemic candidiasis may occur. [37] Treatment Superficial candidiasis should be topical with azole antifungals and the area should be kept clean and dry. [1] Systemic candidosis should be treated with systemic agents like Amphotericin B, Fluconazole and Itraconazole.
Traumatic Lesions During Intensive Care
The complex technology now involved in intensive care includes a number of invasive procedures that can cause cutaneous lesions. [38] Continuous arterial catheterization may lead to bruising or even local or peripheral skin necrosis. Phlebitis may also occur.
Pressure Sores
Pressure sores occur as a result of a localized area of necrosis caused by ischemia, resulting from compression of soft-tissue between a bony prominence and an external surface. The elderly are especially susceptible. [39] The prevalence of pressure sores have decreased in the hospital settings by the introduction of various measures in 1990's. [40] 
Contact Dermatitis
Contact dermatitis is caused by allergens or irritants. Tape, cleansing agents, topical medications may be the offender.
Clinical features-Circumscribed eruption confined to the area of contact is the prime feature. It can present with erythema, vesico-bullous eruption, which may be exuding.
Treatment includes removal of allergen and application of steroid cream.
Miliaria
It results due to obliteration of the eccrine sweat duct. They differ in clinical forms due to different levels at which disruption occurs. [41] It is commonly seen in bedridden patients with fever.
Clinical Features
Miliaria crystalline: Seen as clear dewdrops. It is characterized by small, very superficial vesicles without surrounding inflammation.
Miliaria rubra: Seen as pruritic erythematous papules. Areas such as back of the patients lying on bed, antecubital and popliteal fossa are the sites of predilection.
Treatment
Loose cotton clothing is advisable. Area should be kept dry. Oral antihistamines, medium potency topical steroid or topical antipruritic lotions are helpful. [42] Purpuras It presents as bluish or purple discoloration of the skin varying in size which is non-blanchable. It results from hemorrhage into the skin or mucous membranes. The causes of pupura can be classified as follow [ Table 6 ]. [1] 
Disseminated Intravascular Coagulation/Purpura Fulminans
This is the most deadly clinical manifestation which an intensivist encounters during the routine clinical ICU practice. It is clinically characterized by:
• Fever, hypotension, extensive skin necrosis associated with evidence of disseminated intravascular coagulation (DIC) • Large irregular areas of purpura especially, over the extremities • Skin lesions are tender, enlarge rapidly and may involve into hemorrhagic bullae with subsequent necrosis. Necrosis of the entire extremity may develop.
• Pulmonary, hepatic, renal failure, Gastro-intestinal (GI)
bleeding and hemorrhagic adrenal infarction may occur.
[43]
CONCLUSION
Dermatologic diseases are extremely difficult to diagnose with precision without adequate in-depth knowledge of various pathophysiological aspects and clinical presentation of the diseases. The relative shortage of dermatologists in our country mandates that every physician should be well aware of the management of common skin diseases. Intensivists have to gear up to diagnose, prevent and manage various dermatological disorders in ICU as they can directly or indirectly impact the outcome in critically ill patients. 
